Tango Therapeutics Inc (TNGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Sales | 14,598 | 5,766 | 6,411 | 6,920 | 5,771 |
| Gross Profit | 14,598 | 5,766 | 6,411 | 6,920 | 5,771 |
| Operating Expenses | 37,845 | 36,052 | 36,978 | 36,843 | 30,973 |
| Operating Income | -23,247 | -30,286 | -30,567 | -29,923 | -25,202 |
| Other Income | 2,601 | 2,278 | 1,558 | 873 | 347 |
| Pre-tax Income | -20,646 | -28,008 | -29,009 | -29,050 | -24,855 |
| Income Tax | 64 | N/A | 51 | N/A | 3 |
| Net Income Continuous | -20,710 | -28,008 | -29,060 | -29,050 | -24,858 |
| Net Income | $-20,710 | $-28,008 | $-29,060 | $-29,050 | $-24,858 |
| EPS Basic Total Ops | -0.23 | -0.32 | -0.33 | -0.33 | -0.28 |
| EPS Basic Continuous Ops | -0.23 | -0.32 | -0.33 | -0.33 | -0.28 |
| EPS Diluted Total Ops | -0.23 | -0.32 | -0.33 | -0.33 | -0.28 |
| EPS Diluted Continuous Ops | -0.23 | -0.32 | -0.33 | -0.33 | -0.28 |
| EBITDA(a) | $-23,519 | $-30,598 | $-29,778 | $-29,734 | $-24,881 |